-transparent.png){kind=logo}
Two schedules of teroxirone, a triazine triepoxide, were evaluated in a phase I study. Twenty-six patients were treated on 1 day every 5 weeks at doses of 36-2250 mg/m2. At doses greater than or equal to 1500 mg/m2, severe thrombophlebitis was seen without cytotoxic effect, and this schedule was closed. Twenty-seven patients were treated on 5 days every 5 weeks at daily doses of 16-450 mg/m2. Mild thrombophlebitis and moderate leukopenia were encountered. For phase II studies, a dose of 375 mg/m2 X 5 every 5 weeks is recommended. Pharmacologic studies showed rapid plasma elimination, which suggests the agent's possible usefulness for regional infusion.
Related Publications
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
September 1984,
Cancer treatment reports,
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
May 1989,
European journal of cancer & clinical oncology,
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
June 1983,
Cancer,
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
May 2003,
Oncology (Williston Park, N.Y.),
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
March 2001,
Clinical cancer research : an official journal of the American Association for Cancer Research,
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
December 1998,
Bulletin du cancer,
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
March 2002,
Annals of oncology : official journal of the European Society for Medical Oncology,
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
February 2015,
Cancer chemotherapy and pharmacology,
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
January 2016,
Cancer chemotherapy and pharmacology,
J Rubin, and
J S Kovach, and
M M Ames, and
C G Moertel, and
E T Creagan, and
M J O'Connell
October 2003,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
